Skip to main content

FAQ: Definitions of Menopause and Biological Actions of Sex Steroids

  • Chapter
  • First Online:
Hormone Therapy
  • 1478 Accesses

Abstract

There has been great confusion about the name of this stage of women’s health and reproductive lives, with vagueness to the term menopause, and the introduction of the stage of perimenopause, or premenopause, as something that doctors, and women, are starting to understand on its own. It is helpful to divide menopause into the stages of perimenopause and postmenopause, as women may experience different symptoms during these times, and clinicians may prescribe differently, based on symptoms and on the results of clinical studies and trials of HT efficacy and safety.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  1. Broer SL, Eijkemans JC, Scheffer GJ, et al. Anti-müllerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab. 2011;96(8):2532–9.

    Article  PubMed  CAS  Google Scholar 

  2. Crawford S, Santoro N, Laughlin GA, et al. Circulating dehydroepiandrosterone sulfate concentrations during the menopausal transition. J Clin Endocrinol Metab. 2009;94(8):2945–51.

    Article  PubMed  CAS  Google Scholar 

  3. Do Choi S, Steinberg EM, Hyeog Lee H, Naftolin F. The timing hypothesis remains a valid explanation of differential cardioprotective effects of menopausal hormone treatment [review article]. Menopause. 2011;18(2):230–6.

    Google Scholar 

  4. Freeman EW, Sammel MD, Lin H, Gracia CR. Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab. 2012;97(5):1673–80.

    Article  PubMed  CAS  Google Scholar 

  5. Freeman WE, Sherif K. Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric. 2007;10:197–214.

    Article  PubMed  CAS  Google Scholar 

  6. Gast G-C M, Grobbee DE, Pop VJM, et al. Menopausal complaints are associated with cardiovascular risk factors. Hypertension. 2008;51(6):1492–8.

    Article  PubMed  Google Scholar 

  7. Gavin KM, Seals DR, Silver AE, Moreau KL. Vascular endothelial estrogen receptor alpha is modulated by estrogen status and related to endothelial function and eNOS in healthy women. J Clin Endocrinol Metab. 2009;94(9):3513–20.

    Article  PubMed  CAS  Google Scholar 

  8. Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012;97(4):1159–68.

    Article  PubMed  CAS  Google Scholar 

  9. Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19(4):387–95.

    Article  PubMed  Google Scholar 

  10. Hunter MS, Gentry-Maharaj A, Ryan A, et al. Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross-sectional cohort study of 10 418 British women aged 54–65. BJOG. 2012;119(1):40–50.

    Article  PubMed  CAS  Google Scholar 

  11. Kok HS, van Asselt KM, van der Schouw YT, et al. Heart disease risk determines menopausal age rather than the reverse. J Am Coll Cardiol. 2006;47(10): 1976–83.

    Article  PubMed  Google Scholar 

  12. Konhilas JP, Leinwand LA. The effects of biological sex and diet on the development of heart failure. Circulation. 2007;116:2747–59.

    Article  PubMed  Google Scholar 

  13. Livingstone C, Collison M. Sex steroids and insulin resistance [review]. Clin Sci. 2002;102:151–66.

    Article  PubMed  CAS  Google Scholar 

  14. National Osteoporosis Foundation. 8 Common myths about osteoporosis. Washington, DC: National Osteoporosis Foundation; 2002.

    Google Scholar 

  15. Niland P, Lyons AC. Uncertainty in medicine: meanings of menopause and hormone replacement therapy in medical textbooks. Soc Sci Med. 2011;73:1238–45.

    Article  PubMed  Google Scholar 

  16. Notelovitz M. The clinical practice impact of the Women’s Health Initiative: political vs biological correctness [guest editorial]. Maturitas. 2003;44:3–9.

    Article  PubMed  Google Scholar 

  17. Notelovitz M. The biological rationale for estrogen therapy. Presented at 25 April 2003, Adult Women’s Health & Medicine meeting, Boca Raton, FL and Washington, DC.

    Google Scholar 

  18. O’Connor KA, Ferrell R, Brindle E, et al. Progesterone and ovulation across stages of the transition to menopause. Menopause. 2009;16(6):1178–87.

    Article  PubMed  Google Scholar 

  19. Phillips LS, Langer RD. Postmenopausal hormone therapy: critical reappraisal and a unified hypothesis. Fertil Steril. 2005;83(3):558–66.

    Article  PubMed  CAS  Google Scholar 

  20. Prior JC, Hitchcock CL. The endocrinology of perimenopause: need for a paradigm shift. Front Biosci. 2011;S3:474–86.

    Article  CAS  Google Scholar 

  21. Rybaczyk LA, Bashaw MJ, Pathak DR, et al. An overlooked connection: serotonergic mediation of estrogen-related physiology and pathology. BMC Womens Health. 2005;5:12.

    Article  PubMed  Google Scholar 

  22. Salpeter SR, Walsh JME, Greyber E, Salpeter EE. Coronary heart disease events associated with hormone therapy in younger and older women: a meta-analysis [brief report]. J Gen Intern Med. 2006;12:363–6.

    Article  Google Scholar 

  23. Santoro N, Crawford SL, Lasley WL. Factors related to declining luteal function in women during the menopausal transition. J Clin Endocrinol Metab. 2008;93(5): 1711–21.

    Article  PubMed  CAS  Google Scholar 

  24. Saraç F, Saydam G, Sahin F, et al. Effects of hormone therapy replacement on insulin resistance and platelet function tests. Med Princ Pract. 2009;18:43–7.

    Article  PubMed  Google Scholar 

  25. Sherif K. The effects of hormone replacement therapy and oral contraceptive pills on blood pressure. Prog Cardiovasc Nurs 2000;15(1):21–23,28.

    Google Scholar 

  26. Sherwin BB, Henry JF. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. Front Neuroendocrinol. 2008;29:88–113.

    Article  PubMed  CAS  Google Scholar 

  27. Szmuilowicz ED, Adler GK, Ricchiuti V, et al. Relationships between endogenous sex hormone concentrations and vascular function in postmenopausal women [brief report]. J Clin Endocrinol Metab. 2007;92(12):4738–41.

    Article  PubMed  CAS  Google Scholar 

  28. Erel T, Guralp O. Epilepsy and menopause. Arch Gynecol Obstet. 2011;284(3):749–55.

    Article  PubMed  Google Scholar 

  29. Taylor HS, Manson JE. Update in hormone therapy use in menopause. J Clin Endocrinol Metab. 2011;96(2):255–64.

    Article  PubMed  CAS  Google Scholar 

  30. Tepper PG, Randolph Jr JF, McConnell DS, et al. Trajectory clustering of estradiol and follicle-stimulating hormone during the menopausal transition among women in the Study of Women’s Health across the nation (SWAN). Endocrine Res. 2012;97(8): 2872–80.

    CAS  Google Scholar 

  31. Thurston RC, Santoro N, Matthews KA. Adiposity and hot flashes in midlife women: a modifying role of age. J Clin Endocrinol Metab. 2011;96(10):E1588–95.

    Article  PubMed  CAS  Google Scholar 

  32. van de Weijer PHM. Risks of hormone therapy in the 50–59 year age group. Maturitas. 2008;60:59–64.

    Article  PubMed  Google Scholar 

  33. Wildman RP, Tepper PG, Crawford S, et al. Do changes in sex steroid hormones precede or follow increases in body weight during the menopause transition? Results from The Study of Women’s Health Across the Nation. J Clin Endocrinol Metab. 2012;97(9):E1695–704.

    Article  PubMed  CAS  Google Scholar 

  34. Women’s Health Initiative Investigators Writing Group. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–33.

    Article  Google Scholar 

  35. Xing D, Nozell S, Chen Y-F, et al. Estrogen and mechanisms of vascular protection. Arterioscler Thromb Vasc Biol. 2009;29:289–95.

    Article  PubMed  CAS  Google Scholar 

  36. Yamamoto H, Kitawaki J, Kikuchi N, et al. Effects of estrogens on cholinergic neurons in the rat basal nucleus. J Steroid Biochem Mol Biol. 2007;107:70–9.

    Article  PubMed  CAS  Google Scholar 

  37. Yang X-P, Reckelhoff JF. Estrogen, hormonal replacement therapy and cardiovascular disease. Curr Opin Nephrol Hypertens. 2011;20:133–8.

    Article  PubMed  CAS  Google Scholar 

  38. Zengin K, Tokac M, Akif Duzenli M, et al. Influence of menstrual cycle on cardiac performance. Maturitas. 2007;58:70–4.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sherif, K. (2013). FAQ: Definitions of Menopause and Biological Actions of Sex Steroids. In: Hormone Therapy. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6268-2_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6268-2_1

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-6267-5

  • Online ISBN: 978-1-4614-6268-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics